License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services Dublin, Ireland, and Montreal, Canada: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Université de Montréal (‘UdeM’), a leading Canadian research institution renowned for scientific innovation and technology transfer, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants […]
Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applications REDWOOD CITY, Calif. — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and manufacturing license agreement with Alphazyme LLC, part of Maravai LifeSciences, for multiple […]
The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science, Technology, and Research (A*STAR), and Macrogen, today announced the opening of a […]
The nanopore sequencing pilot programme aims to expand our understanding of the causes of rare genetic disease and cancer and evaluate potential for future routine clinical use. Oxford Nanopore Technologies is entering into a strategic collaboration with UMC Utrecht, one of the leading academic medical centres in the Netherlands, that will aim to explore the […]
Illumina Is the genomic sequencing partner for Otsuka Pharmaceutical Japan’s blood cancer assay HemeSight®, the first-in-Japan comprehensive genomic profiling assay for blood cancer, recently received its first regulatory approval. ‘We are very pleased with the approval of HemeSight in Japan. As Otsuka Pharmaceutical’s technology partner for genomic sequencing, we are proud to support Otsuka and […]
This collaboration will integrate Atinary’s AI-driven and automated process optimization technology with Snapdragon’s state-of-the-art laboratories and process development capabilities to tackle complex challenges in drug development. MENLO PARK, California and LAUSANNE, Switzerland — Atinary Technologies, whose leading no-code AI platform, SDLabsTM, and Self-Driving LabsTM technology are transforming research and development (R&D) of new molecules and chemicals, […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform, to Discovery’s global suite of biospecimen products and specialty lab services supporting customers with clinical research. The strategic partnership leverages Lunaphore’s COMET technology, the only fully-automated, high-throughput, hyperplex […]
New partnership will increase access to BioSkryb’s industry-leading single-cell multiomics technology DURHAM, N.C. – BioSkryb Genomics,a company ushering in the next generation of single-cell technology, today announced a partnership with the Human Cell Atlas (HCA), a global consortium that is mapping every cell type in the human body, creating a 3-dimensional Atlas of human cells to […]
ATCC will provide a broad range of in vivo and in vitro models, as well as specialized reagents, for use in infectious disease treatment and research. Manassas, VA, United States — ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a seven-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract […]
Oxford Nanopore Technologies and King Abdullah University of Science and Technology (KAUST) have signed a Memorandum of Understanding (MoU) to collaborate on the research and development of advanced multi-omics technologies. This strategic collaboration will leverage Oxford Nanopore’s innovative nanopore sequencing technology and KAUST’s strong research base to accelerate scientific discoveries that address critical global health […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
